Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

The Cooper Companies, Inc.

NASDAQ

Market Cap.

19.34B

Avg. Volume

1.15M

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze The Cooper Companies, Inc.!

Still processing it, give me a bit more time...

The Cooper Companies, Inc. News

The Cooper Companies, Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Website screenshot
HealthcareMedical - Instruments & Supplies
coopercos.com

About The Cooper Companies, Inc.

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

The Cooper Companies, Inc. Earnings & Revenue

The Cooper Companies, Inc. Financials

Table Compare

Compare COO metrics with:

   

Earnings & Growth

COO

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

COO

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

COO

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

COO

None

Debt Ratio

--

--

Quick Ratio

--

--

 

The Cooper Companies, Inc. Income

The Cooper Companies, Inc. Balance Sheet

The Cooper Companies, Inc. Cash Flow

The Cooper Companies, Inc. Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsNeutral
Return on EquityNeutral
Return on AssetsBuy
Debt/Equity RatioBuy
Price/Earnings RatioStrong Buy
Price/Book RatioNeutral

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

The Cooper Companies, Inc. Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

0.12

Payment DateDividendFrequency
2023-08-110.03Quarterly
2023-02-100.03Quarterly
2022-08-110.03Quarterly
2022-02-090.03Quarterly
2021-08-110.03Quarterly

Historical Market Cap

Shares Outstanding

The Cooper Companies, Inc. Executives

NameRole
Mr. Albert G. White IIIPresident, Chief Executive Officer & Non-Independent Director
Mr. Daniel G. McBride Esq.Executive Vice President & Chief Operating Officer
Mr. Brian G. AndrewsExecutive Vice President, Chief Financial Officer & Treasurer
Ms. Holly R. SheffieldPresident of CooperSurgical, Inc.
Mr. Gerard H. Warner IIIPresident of CooperVision, Inc.
NameRoleGenderDate of BirthPay
Mr. Albert G. White IIIPresident, Chief Executive Officer & Non-Independent DirectorMale19702.91M
Mr. Daniel G. McBride Esq.Executive Vice President & Chief Operating OfficerMale19641.6M
Mr. Brian G. AndrewsExecutive Vice President, Chief Financial Officer & TreasurerMale19791.22M
Ms. Holly R. SheffieldPresident of CooperSurgical, Inc.Female19711.1M
Mr. Gerard H. Warner IIIPresident of CooperVision, Inc.Male19651M

The Cooper Companies, Inc. Insider Trades

Date1 Apr
NameWEISS ROBERT S
RoleDirector
TransactionAcquired
TypeM-Exempt
Shares3180
Date1 Apr
NameWEISS ROBERT S
RoleDirector
TransactionDisposed
TypeM-Exempt
Shares3180
Date1 Apr
NameWEISS ROBERT S
RoleDirector
TransactionAcquired
TypeA-Award
Shares2993
Date1 Apr
NameRivas Maria
RoleDirector
TransactionAcquired
TypeM-Exempt
Shares2892
Date1 Apr
NameRivas Maria
RoleDirector
TransactionDisposed
TypeM-Exempt
Shares2892
DateNameRoleTransactionTypeShares
1 AprWEISS ROBERT SDirectorAcquiredM-Exempt3180
1 AprWEISS ROBERT SDirectorDisposedM-Exempt3180
1 AprWEISS ROBERT SDirectorAcquiredA-Award2993
1 AprRivas MariaDirectorAcquiredM-Exempt2892
1 AprRivas MariaDirectorDisposedM-Exempt2892

Discover More

Streamlined Academy

The Cooper Companies, Inc.

NASDAQ

Market Cap.

19.34B

Avg. Volume

1.15M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

The Cooper Companies, Inc. News

The Cooper Companies, Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

The Cooper Companies, Inc. Earnings & Revenue

The Cooper Companies, Inc. Income

The Cooper Companies, Inc. Balance Sheet

The Cooper Companies, Inc. Cash Flow

The Cooper Companies, Inc. Financials Over Time

The Cooper Companies, Inc. Executives

NameRole
Mr. Albert G. White IIIPresident, Chief Executive Officer & Non-Independent Director
Mr. Daniel G. McBride Esq.Executive Vice President & Chief Operating Officer
Mr. Brian G. AndrewsExecutive Vice President, Chief Financial Officer & Treasurer
Ms. Holly R. SheffieldPresident of CooperSurgical, Inc.
Mr. Gerard H. Warner IIIPresident of CooperVision, Inc.
NameRoleGenderDate of BirthPay
Mr. Albert G. White IIIPresident, Chief Executive Officer & Non-Independent DirectorMale19702.91M
Mr. Daniel G. McBride Esq.Executive Vice President & Chief Operating OfficerMale19641.6M
Mr. Brian G. AndrewsExecutive Vice President, Chief Financial Officer & TreasurerMale19791.22M
Ms. Holly R. SheffieldPresident of CooperSurgical, Inc.Female19711.1M
Mr. Gerard H. Warner IIIPresident of CooperVision, Inc.Male19651M

The Cooper Companies, Inc. Insider Trades

Date1 Apr
NameWEISS ROBERT S
RoleDirector
TransactionAcquired
TypeM-Exempt
Shares3180
Date1 Apr
NameWEISS ROBERT S
RoleDirector
TransactionDisposed
TypeM-Exempt
Shares3180
Date1 Apr
NameWEISS ROBERT S
RoleDirector
TransactionAcquired
TypeA-Award
Shares2993
Date1 Apr
NameRivas Maria
RoleDirector
TransactionAcquired
TypeM-Exempt
Shares2892
Date1 Apr
NameRivas Maria
RoleDirector
TransactionDisposed
TypeM-Exempt
Shares2892
DateNameRoleTransactionTypeShares
1 AprWEISS ROBERT SDirectorAcquiredM-Exempt3180
1 AprWEISS ROBERT SDirectorDisposedM-Exempt3180
1 AprWEISS ROBERT SDirectorAcquiredA-Award2993
1 AprRivas MariaDirectorAcquiredM-Exempt2892
1 AprRivas MariaDirectorDisposedM-Exempt2892

Streamlined Academy

Website screenshot
HealthcareMedical - Instruments & Supplies
coopercos.com

About The Cooper Companies, Inc.

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze The Cooper Companies, Inc.!

Still processing it, give me a bit more time...

The Cooper Companies, Inc. Financials

Table Compare

Compare COO metrics with:

   

Earnings & Growth

COO

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

COO

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

COO

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

COO

None

Debt Ratio

--

--

Quick Ratio

--

--

 

The Cooper Companies, Inc. Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

0.12

Payment DateDividendFrequency
2023-08-110.03Quarterly
2023-02-100.03Quarterly
2022-08-110.03Quarterly
2022-02-090.03Quarterly
2021-08-110.03Quarterly

The Cooper Companies, Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsNeutral
Return on EquityNeutral
Return on AssetsBuy
Debt/Equity RatioBuy
Price/Earnings RatioStrong Buy
Price/Book RatioNeutral

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More